Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

PURICORE PLC (PURI)

1
Delayed Quote. Delayed London Stock Exchange - 04/17 10:43:21 am
45.15 GBp   -1.85%
04/10 PURICORE : Notice of Results
02/19 PURICORE PLC : Blocklisting Interim Review
02/18 PURICORE PLC : Trading Statement
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

PuriCore plc : PuriCore Raises $3.5 Million

01/03/2012 | 03:11pm US/Eastern
Recommend:
0
PuriCore plc ("PuriCore" or the "Company" or the "Group") PuriCore Raises $3.5 Million MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 January 2012 - PuriCore (LSE: PURI), the water- based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that it closed on a new $3.5 million debt facility with Republic Bank on 29 December 2011. The debt will be utilized to finance the working capital requirements associated with Sterilox Fresh and FloraFresh System installations in H1 2012. The facility is structured as a promissory note with an imputed interest rate of 4%. Enquiries:

FTI Consulting Susan Quigley Ben Brewerton

+44 (0) 20 7831 3113

About PuriCore

PuriCoreplc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. PuriCore's solutions are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

1

Recommend :
0
React to this article
Latest news on PURICORE PLC
04/10 PURICORE : Notice of Results
02/19 PURICORE PLC : Blocklisting Interim Review
02/18 PURICORE PLC : Trading Statement
02/13 PURICORE PLC : Middle East Wound Care Marketing Agreement
01/24 PURICORE PLC : Puricore Assigned Patent
2013 PURICORE PLC : Re Agreement
2013 PURICORE PLC : Holding(s) in Company
2013 PURICORE PLC : Holding(s) in Company
2013 PURICORE PLC : Director/PDMR Shareholding
2013 PURICORE PLC : Interim Management Statement
Advertisement
Chart
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Income Statement Evolution
PuriCore plc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF